St. Joseph’s Medical Center located in Stockton will participate in the Abiomed Mobile Learning Lab program on Dec. 14, 2016 at 11 a.m. The Mobile Learning Lab is a highly interactive, facilitated learning experience that is brought directly to the hospital with the goal of training hospital staff on the Impella® heart pump, one of the newest, minimally invasive heart support and recovery technologies. The Impella is manufactured by Abiomed, Inc.
Impella, the world’s smallest heart pump, is a percutaneous (through the skin) heart pump that offers hemodynamic support for patients during certain heart procedures – essentially assisting the pumping function of the heart. The Impella family of left side heart pumps was recently approved by the FDA to provide treatment of ongoing cardiogenic shock, an often fatal condition that typically occurs during or after a heart attack. The Impella is the only minimally invasive heart pump that has been approved as safe and effective by the U.S. FDA for this use in the United States. The Impella 2.5™ heart pump, the smallest of the Impella devices, can also be used to provide temporary ventricular support during elective and urgent, high risk percutaneous coronary intervention (PCI) procedures.
The Mobile Learning Lab will offer cardiologists, nurses and cath lab staff at St. Joseph’s Medical Center a convenient opportunity to learn about the Impella platform and how these heart pumps can best be used for those patients in critical need of cardiac support. The Mobile Learning Lab contains various Impella simulators, animations and key information, which are all presented by a team of Abiomed trainers.
Abiomed's portfolio of heart support and recovery products and services offers healthcare professionals an array of choices across a broad clinical spectrum. The Impella heart pump family has now supported more than 37,673 patients in the United States – enough to fill every seat in Fenway Park.